Discovery of Novel Small-Molecule Immunomodulators for Cancer Immunotherapy Using OB2C Technology

<b>Background/Objective:</b> Immunomodulators play a critical role in regulating immune responses, with immunostimulatory agents enhancing cancer therapy by activating immune cells such as T cells. While immune checkpoint inhibitors (ICIs) targeting PD-1 and CTLA-4 have shown clinical su...

Full description

Saved in:
Bibliographic Details
Main Authors: Hsiao-Chi Wang, Tsung-Chieh Shih
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Journal of Molecular Pathology
Subjects:
Online Access:https://www.mdpi.com/2673-5261/6/1/4
Tags: Add Tag
No Tags, Be the first to tag this record!